Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues

Kamp P-B, Strathmann A, Ragg H (2001)
THROMBOSIS RESEARCH 101(6): 483-491.

Journal Article | Published | English

No fulltext has been uploaded

Abstract
In the presence of glycosaminoglycans, thrombin is rapidly inactivated by two natural inhibitors secreted from liver: antithrombin (AT) is presumed to be the principal thrombin inhibitor in circulating blood, while for heparin cofactor II (HCII), a role outside circulation has been proposed. In this study, we show that HCII and AT differ with respect to their association with human tissues. Aside from brain, each of these inhibitors was found in sodium dodecyl sulphate (SDS) soluble extracts of various human organs, with a preponderance of HCII in placenta. AT levels, however, predominated in liver. Compared to plasma, the beta -variant of AT was found to be strongly enriched in human organs, while tissue-resident HCII did not differ in its electrophoretic mobility from the circulating form. In placenta, comparable amounts of HCII/thrombin and AT/thrombin complexes were detected, indicating that HCII may exert a thrombin regulating role in that organ under conditions of tissue or blood vessel damage. Transcripts coding for HCII and AT were detected in all tissues examined. The low levels of their mRNAs suggest that most of the tissue-associated thrombin inhibitor molecules originate from circulation and are retained in organs, possibly by specific receptors. The differential presence of HCII and AT in organs is in accordance with individual physiological roles of these inhibitors. (C) 2001 Elsevier Science Ltd. All rights reserved.
Publishing Year
ISSN
PUB-ID

Cite this

Kamp P-B, Strathmann A, Ragg H. Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. THROMBOSIS RESEARCH. 2001;101(6):483-491.
Kamp, P. - B., Strathmann, A., & Ragg, H. (2001). Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. THROMBOSIS RESEARCH, 101(6), 483-491.
Kamp, P. - B., Strathmann, A., and Ragg, H. (2001). Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. THROMBOSIS RESEARCH 101, 483-491.
Kamp, P.-B., Strathmann, A., & Ragg, H., 2001. Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. THROMBOSIS RESEARCH, 101(6), p 483-491.
P.-B. Kamp, A. Strathmann, and H. Ragg, “Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues”, THROMBOSIS RESEARCH, vol. 101, 2001, pp. 483-491.
Kamp, P.-B., Strathmann, A., Ragg, H.: Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues. THROMBOSIS RESEARCH. 101, 483-491 (2001).
Kamp, Paul-Bertram, Strathmann, Annemarie, and Ragg, Hermann. “Heparin cofactor II, antithrombin-beta and their complexes with thrombin in human tissues”. THROMBOSIS RESEARCH 101.6 (2001): 483-491.
This data publication is cited in the following publications:
This publication cites the following data publications:

6 Citations in Europe PMC

Data provided by Europe PubMed Central.

Heparin co-factor II enhances cell motility and promotes metastasis in non-small cell lung cancer.
Liao WY, Ho CC, Hou HH, Hsu TH, Tsai MF, Chen KY, Chen HY, Lee YC, Yu CJ, Lee CH, Yang PC., J. Pathol. 235(1), 2015
PMID: 25130770
Effect of microgravity on gene expression in mouse brain.
Frigeri A, Iacobas DA, Iacobas S, Nicchia GP, Desaphy JF, Camerino DC, Svelto M, Spray DC., Exp Brain Res 191(3), 2008
PMID: 18704384
Fatal thrombosis of antithrombin-deficient mice is rescued differently in the heart and liver by intercrossing with low tissue factor mice.
Hayashi M, Matsushita T, Mackman N, Ito M, Adachi T, Katsumi A, Yamamoto K, Takeshita K, Kojima T, Saito H, Murohara T, Naoe T., J. Thromb. Haemost. 4(1), 2006
PMID: 16409467
Adenovirus-mediated expression of heparin cofactor II inhibits thrombin-induced cellular responses in fibroblasts and vascular smooth muscle cells.
Hayakawa Y, Hirashima Y, Yamamoto H, Hayashi N, Kurimoto M, Kuwayama N, Endo S., Thromb. Res. 116(4), 2005
PMID: 16038721
Localization of heparin cofactor II in injured human skin: a potential role in wound healing.
Hoffman M, Loh KL, Bond VK, Palmieri D, Ryan JL, Church FC., Exp. Mol. Pathol. 75(2), 2003
PMID: 14516771

40 References

Data provided by Europe PubMed Central.

Antithrombin: structure and function
Sheffield, 1995
Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo
Liu, Thromb Haemostasis 73(), 1995
Familial overexpression of beta antithrombin caused by an Asn135Thr substitution.
Bayston TA, Tripodi A, Mannucci PM, Thompson E, Ireland H, Fitches AC, Hananeia L, Olds RJ, Lane DA., Blood 93(12), 1999
PMID: 10361121
Transgenically produced human antithrombin: structural and functional comparison to human plasma-derived antithrombin.
Edmunds T, Van Patten SM, Pollock J, Hanson E, Bernasconi R, Higgins E, Manavalan P, Ziomek C, Meade H, McPherson JM, Cole ES., Blood 91(12), 1998
PMID: 9616152
Thrombin-inhibitor complexes in the blood during and after delivery.
Andersson T, Lorentzen B, Hogdahl H, Clausen T, Mowinckel MC, Abildgaard U., Thromb. Res. 82(2), 1996
PMID: 9163064
An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus.
Andrew M, Mitchell L, Berry L, Paes B, Delorme M, Ofosu F, Burrows R, Khambalia B., J. Clin. Invest. 89(1), 1992
PMID: 1729278
Anticoagulant dermatan sulfate proteoglycan (decorin) in the term human placenta.
Delorme MA, Xu L, Berry L, Mitchell L, Andrew M., Thromb. Res. 90(4), 1998
PMID: 9692613
Interaction of heparin cofactor II with biglycan and decorin.
Whinna HC, Choi HU, Rosenberg LC, Church FC., J. Biol. Chem. 268(6), 1993
PMID: 8440685
Cell biology of arterial proteoglycans.
Wight TN., Arteriosclerosis 9(1), 1989
PMID: 2643420
Activation of heparin cofactor II by fibroblasts and vascular smooth muscle cells.
McGuire EA, Tollefsen DM., J. Biol. Chem. 262(1), 1987
PMID: 3793724
Regulation of extravascular coagulation by microvascular permeability.
Dvorak HF, Senger DR, Dvorak AM, Harvey VS, McDonagh J., Science 227(4690), 1985
PMID: 3975602
Vascular permeability factor/vascular endothelial growth factor and the significance of microvascular hyperpermeability in angiogenesis.
Dvorak HF, Nagy JA, Feng D, Brown LF, Dvorak AM., Curr. Top. Microbiol. Immunol. 237(), 1999
PMID: 9893348
Cloning and expression of the cDNA for human antithrombin III.
Bock SC, Wion KL, Vehar GA, Lawn RM., Nucleic Acids Res. 10(24), 1982
PMID: 6298709

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 11323006
PubMed | Europe PMC

Search this title in

Google Scholar